Executive Summary: Overcoming Pharma's Global Challenges by Embracing Technology

In an era of geopolitical uncertainties, supply chain disruptions, and rising costs, the global Pharma industry can embrace AI & other technologies and
orchestrate favourable outcomes such as digitalized supply chains, accelerated drug discovery, & enhanced customer experiences etc.

Key Forces Affecting Global Pharma Industry Opportunities to Accelerate Through Technology

Operating Environment Growth Enabler Constraint Both

Research & Development
Activities Influencing Global Concerns New Developments AI / ML
Industry
Geopolitical Concerns Technological Advancement
Covid Led Uncertainties Industry 4.0 Revolution
Supply Chain Disruptions ESG Expectations Cloud
Labor Market Challenges Contract Low
Technology High
Manufac-- Improved customer
-turing experience

Pharma Industry Supply Chain & Manufacturing

Resilient
Supply Chain Business Accelerated
Drug Discovery
Outcomes
Industry influencing Build Supply Chain Pressure to Innovate &
environment Resilience adapt
Diffusion of individual Alternate Analytics
players’ power Sourcing & Insights Low High
Digitized Efficiency
Supply Chain Improvement
High Dependence on China
Marketing & Launch
Chinese APIs account for around 70% of all APIs in imports
• Drug Shortages
• High Cost External
Supply Disruption and Cost Trends Technology
• Increased Healthcare
~50% - 200% price increase due to COVID disruption, trade Partnerships
Burden
wars, Russia-Ukraine conflict, inflation etc.
• Jobs Cuts
• Shutdown of Companies
Increasing Healthcare Costs and Decrease in Capex Low High
Cost of treatment to increase and pharma firms reduce capex

01
Source:(AI In Pharmaceutical Market Size, Share, Report 2021-2030, n.d.); (Adopting AI in Drug Discovery, 2022); (The Economic Potential of Generative AI: The Next Productivity Frontier, 2023); (Verheles, 2022)